comparemela.com
  1. Home
  2. Live Updates
  3. Optimizing Treatment Approaches - Breaking News

Latest Breaking News On - Optimizing treatment approaches - Page 1 : comparemela.com

Unmet Needs and Future Perspectives in Colorectal Cancer

Unmet Needs and Future Perspectives in Colorectal Cancer
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Adverse event managementColorectal cancerOptimizing treatment approachesFuture perspectives

Multidisciplinary Care for Patients with CRC

Clinical insights on the roles of various members within a multidisciplinary team involved in the care of patients with colorectal cancer.

Adverse event managementColorectal cancerOptimizing treatment approaches

Toxicity Considerations and Treatment Decisions in CRC

Experts on colorectal cancer discuss the treatment decision-making process, highlighting the safety profiles of fruquintinib and regorafenib.

Adverse event managementColorectal cancerOptimizing treatment approachesTreatment decisionsColorectal cancer treatmentMcrc treatmentSafety profileFresco 2

Monitoring and AE Management Strategies with Fruquintinib in CRC

Margot O'Neill, PA-C, MHS, and Michael Leung, PharmD, discuss the monitoring and adverse effect management strategies for patients with colorectal cancer who receive fruquintinib.

Adverse event managementColorectal cancerOptimizing treatment approachesColorectal cancer treatmentMcrc treatmentAdverse effectsAdverse effect managementMae managementMonitoring strategies

FRESCO-2: Fruquintinib in Patients with Refractory Metastatic CRC

Arvind N. Dasari, MD, MS, provides a comprehensive overview of the FRESCO-2 trial investigating fruquintinib in patients with refractory metastatic colorectal cancer.

Adverse event managementColorectal cancerOptimizing treatment approachesRefractory metastaticColorectal cancer treatmentMcrc treatmentFresco 2Refractory colorectal cancerRefractory crcTas 102Safety profileSunlight trial

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.